NBI bronchoscopy could improve early lung cancer detection

Lung cancer treatment could be improved thanks to the development of a new early detection technique.

According to research by scientists from the University of Heidelberg in Germany, the use of narrow-band imaging (NBI) bronchoscopy allows for more accurate detection of the disease at an early stage.

The team's findings, which are published in the Jounral of Thoracic Oncology, indicated that there is a strong correlation between the early detection of non-small cell lung cancer and improved treatment rates.

NBI bronchoscopies offer an alternative and improved way of identifying these cancerous cells to the conventional auto-fluorescence imaging (AFI) process, according to the scientists.

Dr Felix Herth, of the university's department of pneumology and critical care medicine, said: "This research shows that when diagnosing early stage lung cancer, using NBI may be a better option than AFI because it increases specificity without compromising sensitivity."

Last week, it was claimed that early diagnosis of ovarian cancer could allow for far more effective treatments.

Target Ovarian Cancer said that women diagnosed early have a survival rate of 90 per cent.

Comment on this page »


Latest news

AXA PPP healthcare win at UK Customer Experience awards 2015

David Mobbs retires as CEO of Nuffield Health

King's victorious at World Transplant Games

NBI bronchoscopy could improve early lung cancer detection
Connect with us on:

This site compiles with the HONcode standard for trustworthy health information